Involvement of IL-18 and soluble Fas in patients with postoperative hepatic failure

European Surgical Research

Volumn 35, Issue 2, 2003, Pages 61-66

  Nakae, Hajime ^a   Zheng, Y J ^a   Wada, H ^a   Tajimi, K ^a   Endo, S ^b  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

IL 18; Postoperative hepatic failure; Soluble Fas; Tumor necrosis factor alpha

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 18; INTERLEUKIN 6; ISOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; LIVER CELL; LIVER FAILURE; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEPSIS; SURVIVAL;

AGED; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATOCYTES; HUMANS; INTERLEUKIN-18; LIVER FAILURE, ACUTE; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037251045     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069395     Document Type: Article

References (32)

1. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L: Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
2. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-809.
3. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279.
4. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 1994;265:528-530.
5. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994;370:650-652.
6. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;154:3806-3813.
7. Leist M, Gantner F, Bohlinger L, Tiegs G, Germann PG, Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995;146:1220-1223.
8. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J, Nagata S: Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 1994;215:332-337.
9. Shinagawa T, Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M: Apoptosis in cultured rat hepatocytes: The effects of tumour necrosis factor alpha and interferon gamma. J Pathol 1991;165:247-253.
10. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S: Essential roles of the Fas ligand in the development of hepatitis. Nat Med 1997;3:409-413.
11. Nakae H, Narita K, Endo S: Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure. J Crit Care 2001;16:59-63.
12. Nakae H, Yonekawa C, Narita K, Endo S: Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? Res Commun Mol Pathol Pharmacol 2001;109:65-72.
13. Nakae H, Yonekawa C, Wada H, Asanuma Y, Sato T, Tanaka H: Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure. Ther Apher 2001;5:471-475.
14. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K: Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995;378:88-91.
15. Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, Higashino K, Nakanishi K: IL-18 accounts for both TNF-α and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997;159:3961-3967.
16. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, Kaneda K: IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996;157:3967-3973.
17. Matsubara S, Okabe K, Ouchi K, Miyazaki Y, Yajima Y, Suzuki H, Otsuki M, Matsuno S: Continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit Care Med 1990;18:1331-1338.
18. Sekiyama KD, Yoshiba M, Thomson AW: Circulating proinflammatory cytokines (IL-1β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994;98:71-77.
19. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
20. Sheron N, Goka J, Wendon J: Highly elevated plasma cytokines in fulminant hepatic failure: Correlation with multi-organ failure and death (abstract). Hepatology 1990;12:939.
21. Colletti LM, Cortis A, Lukacs N, Kunkel SL, Green M, Strieter RM: Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998;10:182-191.
22. Sato T, Asanuma Y, Masaki Y, Sato Y, Hatakeyama Y, Kusano T, Koyama K: Changes in tumor necrosis factor-α and interleukin-1β production following liver surgery on cirrhotic patients. Hepatogastroenterology 1996;43:1148-1153.
23. Nagata S: Apoptosis by death factor. Cell 1997;88:355-365.
24. Nagata S, Golstein P: The Fas death factor. Science 1995;267:1449-1456.
25. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
26. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263:1759-1762.
27. Tsutsui H, Kayagaki N, Kuida K, Nakano H, Hayashi N, Takeda K, Matsui K, Kashiwamura S, Hada T, Akira S, Yagita H, Okamura H, Nakanishi K: Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 1999;11:359-367.
28. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001;19:423-474.
29. Hoshino T, Wiltrout RH, Young HA: IL-18 is a potent coinducer of IL-13 in NK and T cells: A new potential role for IL-18 in modulating the immune response. J Immunol 1999;162:5070-5077.
30. Takehara T, Hayashi N, Mita E, Kanto T, Tatsumi T, Sasaki Y, Kasahara A, Hori M: Delayed Fas-mediated hepatocyte apoptosis during liver regeneration in mice: Hepatoprotective role of TNF-α. Hepatology 1998;27:1643-1651.
31. Yamada Y, Kirillova I, Peschon JJ, Fausto N: Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997;94:1441-1446.
32. Endo S, Yamada Y, Inada K, Nakae H: Interleukin-18 levels in patients with infectious burns; in Endo S (ed): BURN - Mediators and Pathophysiology. Tokyo, Influx Press, 2001, pp 55-59.